{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:48:57Z","timestamp":1787240937677,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 AI165077"],"award-info":[{"award-number":["P01 AI165077"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 AI165077"],"award-info":[{"award-number":["P01 AI165077"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 AI165077"],"award-info":[{"award-number":["P01 AI165077"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 AI165077"],"award-info":[{"award-number":["P01 AI165077"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institutes of Health, United States","award":["T32 EB021962"],"award-info":[{"award-number":["T32 EB021962"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Viruses"],"DOI":"10.1038\/s44298-025-00142-9","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T19:34:19Z","timestamp":1753817659000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Merbecovirus S2 subunit vaccines elicit cross reactive antibodies and provide partial protection against MERS coronavirus"],"prefix":"10.1038","volume":"3","author":[{"given":"Peter J.","family":"Halfmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustine","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingcheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie E.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth R.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kawaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi S.","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"142_CR1","unstructured":"Middle East Respiratory Syndrome coronavirus\u2014Kingdom of Saudi Arabia, https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2025-DON560 (2025)."},{"key":"142_CR2","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.cell.2023.01.019","volume":"186","author":"J Chen","year":"2023","unstructured":"Chen, J. et al. A bat MERS-like coronavirus circulates in pangolins and utilizes human DPP4 and host proteases for cell entry. Cell 186, 850\u2013863.e816 (2023).","journal-title":"Cell"},{"key":"142_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45453-2","volume":"15","author":"LY Xia","year":"2024","unstructured":"Xia, L. Y. et al. Isolation and characterization of a pangolin-borne HKU4-related coronavirus that potentially infects human-DPP4-transgenic mice. Nat. Commun. 15, 1048 (2024).","journal-title":"Nat. Commun."},{"key":"142_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20458-9","volume":"12","author":"SKP Lau","year":"2021","unstructured":"Lau, S. K. P. et al. Isolation of MERS-related coronavirus from lesser bamboo bats that uses DPP4 and infects human-DPP4-transgenic mice. Nat. Commun. 12, 216 (2021).","journal-title":"Nat. Commun."},{"key":"142_CR5","doi-asserted-by":"publisher","first-page":"12516","DOI":"10.1073\/pnas.1405889111","volume":"111","author":"Y Yang","year":"2014","unstructured":"Yang, Y. et al. Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus. Proc. Natl. Acad. Sci. USA 111, 12516\u201312521 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"142_CR6","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.chom.2014.08.009","volume":"16","author":"Q Wang","year":"2014","unstructured":"Wang, Q. et al. Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26. Cell Host Microbe 16, 328\u2013337 (2014).","journal-title":"Cell Host Microbe"},{"key":"142_CR7","doi-asserted-by":"crossref","unstructured":"Menachery, V. D. et al. Trypsin treatment unlocks barrier for zoonotic bat coronavirus infection. J. Virol. 94, 10\u20131128 (2020).","DOI":"10.1128\/JVI.01774-19"},{"key":"142_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/infdis\/jiy018","volume":"218","author":"SKP Lau","year":"2018","unstructured":"Lau, S. K. P. et al. Receptor usage of a novel bat lineage c betacoronavirus reveals evolution of middle east respiratory syndrome-related coronavirus spike proteins for human dipeptidyl peptidase 4 binding. J. Infect. Dis. 218, 197\u2013207 (2018).","journal-title":"J. Infect. Dis."},{"key":"142_CR9","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/j.cell.2024.12.032","volume":"188","author":"Y-J Park","year":"2025","unstructured":"Park, Y.-J. et al. Molecular basis of convergent evolution of ACE2 receptor utilization among HKU5 coronaviruses. Cell 188, 1711\u20131728.e1721 (2025).","journal-title":"Cell"},{"key":"142_CR10","doi-asserted-by":"crossref","unstructured":"Catanzaro, N. J. et al. ACE2 from Pipistrellus abramus bats is a receptor for HKU5 coronaviruses. Nat. Commun. 16, 4932 (2025).","DOI":"10.1038\/s41467-025-60286-3"},{"key":"142_CR11","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41586-022-05513-3","volume":"612","author":"Q Xiong","year":"2022","unstructured":"Xiong, Q. et al. Close relatives of MERS-CoV in bats use ACE2 as their functional receptors. Nature 612, 748\u2013757 (2022).","journal-title":"Nature"},{"key":"142_CR12","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2025.01.042","volume":"188","author":"J Chen","year":"2025","unstructured":"Chen, J. et al. Bat-infecting merbecovirus HKU5-CoV lineage 2 can use human ACE2 as a cell entry receptor. Cell 188, 1729\u20131742.e1716 (2025).","journal-title":"Cell"},{"key":"142_CR13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nature17200","volume":"531","author":"RN Kirchdoerfer","year":"2016","unstructured":"Kirchdoerfer, R. N. et al. Pre-fusion structure of a human coronavirus spike protein. Nature 531, 118\u2013121 (2016).","journal-title":"Nature"},{"key":"142_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nrm1076","volume":"4","author":"PM Colman","year":"2003","unstructured":"Colman, P. M. & Lawrence, M. C. The structural biology of type I viral membrane fusion. Nat. Rev. Mol. Cell Biol. 4, 309\u2013319 (2003).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"142_CR15","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3390\/v4061011","volume":"4","author":"S Belouzard","year":"2012","unstructured":"Belouzard, S., Millet, J. K., Licitra, B. N. & Whittaker, G. R. Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses 4, 1011\u20131033 (2012).","journal-title":"Viruses"},{"key":"142_CR16","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/S2666-5247(21)00193-2","volume":"3","author":"M Bosaeed","year":"2022","unstructured":"Bosaeed, M. et al. Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial. Lancet Microbe 3, e11\u2013e20 (2022).","journal-title":"Lancet Microbe"},{"key":"142_CR17","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S1473-3099(20)30248-6","volume":"20","author":"T Koch","year":"2020","unstructured":"Koch, T. et al. Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial. Lancet Infect. Dis. 20, 827\u2013838 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"142_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100685","volume":"3","author":"LM Weskamm","year":"2022","unstructured":"Weskamm, L. M. et al. Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine. Cell Rep. Med. 3, 100685 (2022).","journal-title":"Cell Rep. Med."},{"key":"142_CR19","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S1473-3099(20)30160-2","volume":"20","author":"PM Folegatti","year":"2020","unstructured":"Folegatti, P. M. et al. Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial. Lancet Infect. Dis. 20, 816\u2013826 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"142_CR20","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1126\/science.abf6840","volume":"371","author":"AA Cohen","year":"2021","unstructured":"Cohen, A. A. et al. Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice. Science 371, 735\u2013741 (2021).","journal-title":"Science"},{"key":"142_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/science.abq0839","volume":"377","author":"AA Cohen","year":"2022","unstructured":"Cohen, A. A. et al. Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models. Science 377, eabq0839 (2022).","journal-title":"Science"},{"key":"142_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105649","volume":"25","author":"M Brinkkemper","year":"2022","unstructured":"Brinkkemper, M. et al. Co-display of diverse spike proteins on nanoparticles broadens sarbecovirus neutralizing antibody responses. iScience 25, 105649 (2022).","journal-title":"iScience"},{"key":"142_CR23","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1002\/jmv.27885","volume":"94","author":"P Du","year":"2022","unstructured":"Du, P. et al. A bivalent vaccine containing D614G and BA.1 spike trimer proteins or a BA.1 spike trimer protein booster shows broad neutralizing immunity. J. Med. Virol. 94, 4287\u20134293 (2022).","journal-title":"J. Med. Virol."},{"key":"142_CR24","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/s41565-024-01655-9","volume":"19","author":"RA Hills","year":"2024","unstructured":"Hills, R. A. et al. Proactive vaccination using multiviral Quartet Nanocages to elicit broad anti-coronavirus responses. Nat. Nanotechnol. 19, 1216\u20131223 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"142_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-55824-y","volume":"16","author":"PJ Halfmann","year":"2025","unstructured":"Halfmann, P. J. et al. Multivalent S2 subunit vaccines provide broad protection against Clade 1 sarbecoviruses in female mice. Nat. Commun. 16, 462 (2025).","journal-title":"Nat. Commun."},{"key":"142_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104341","volume":"86","author":"PJ Halfmann","year":"2022","unstructured":"Halfmann, P. J. et al. Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses. EBioMedicine 86, 104341 (2022).","journal-title":"EBioMedicine"},{"key":"142_CR27","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1016\/j.apsb.2023.05.030","volume":"13","author":"Y Lu","year":"2023","unstructured":"Lu, Y. et al. HR121 targeting HR2 domain in S2 subunit of spike protein can serve as a broad-spectrum SARS-CoV-2 inhibitor via intranasal administration. Acta Pharm Sin. B 13, 3339\u20133351 (2023).","journal-title":"Acta Pharm Sin. B"},{"key":"142_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43638-9","volume":"14","author":"AB Kapingidza","year":"2023","unstructured":"Kapingidza, A. B. et al. Engineered immunogens to elicit antibodies against conserved coronavirus epitopes. Nat. Commun. 14, 7897 (2023).","journal-title":"Nat. Commun."},{"key":"142_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45404-x","volume":"15","author":"C-L Hsieh","year":"2024","unstructured":"Hsieh, C.-L. et al. Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge. Nat. Commun. 15, 1553 (2024).","journal-title":"Nat. Commun."},{"key":"142_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49656-5","volume":"15","author":"J Lee","year":"2024","unstructured":"Lee, J. et al. A broadly generalizable stabilization strategy for sarbecovirus fusion machinery vaccines. Nat. Commun. 15, 5496 (2024).","journal-title":"Nat. Commun."},{"key":"142_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41661-4","volume":"14","author":"GB Hutchinson","year":"2023","unstructured":"Hutchinson, G. B. et al. Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive antibody response against diverse coronavirus subgenera. Nat. Commun. 14, 6195 (2023).","journal-title":"Nat. Commun."},{"key":"142_CR32","doi-asserted-by":"crossref","unstructured":"Halfmann, P. J. et al. Broad protection against clade 1 sarbecoviruses after a single immunization with cocktail spike-protein-nanoparticle vaccine. Nat. Commun. 15, 1284 (2024).","DOI":"10.1038\/s41467-024-45495-6"},{"key":"142_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109929","volume":"37","author":"CL Hsieh","year":"2021","unstructured":"Hsieh, C. L. et al. Stabilized coronavirus spike stem elicits a broadly protective antibody. Cell Rep. 37, 109929 (2021).","journal-title":"Cell Rep."},{"key":"142_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202002140","volume":"10","author":"A Castro","year":"2021","unstructured":"Castro, A., Carreno, J. M., Duehr, J., Krammer, F. & Kane, R. S. Refocusing the immune response to selected epitopes on a Zika virus protein antigen by nanopatterning. Adv. Health. Mater. 10, e2002140 (2021).","journal-title":"Adv. Health. Mater."},{"key":"142_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202202729","volume":"12","author":"SJ Frey","year":"2023","unstructured":"Frey, S. J. et al. Nanovaccines displaying the influenza virus hemagglutinin in an inverted orientation elicit an enhanced stalk-directed antibody response. Adv. Health. Mater. 12, e2202729 (2023).","journal-title":"Adv. Health. Mater."},{"key":"142_CR36","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s42003-021-02128-8","volume":"4","author":"S Chiba","year":"2021","unstructured":"Chiba, S. et al. Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization. Commun. Biol. 4, 597 (2021).","journal-title":"Commun. Biol."},{"key":"142_CR37","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.4049\/jimmunol.172.4.2453","volume":"172","author":"ACM Boon","year":"2004","unstructured":"Boon, A. C. M. et al. Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes1. J. Immunol. 172, 2453\u20132460 (2004).","journal-title":"J. Immunol."},{"key":"142_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101191","volume":"41","author":"SH Ebrahim","year":"2021","unstructured":"Ebrahim, S. H. et al. MERS-CoV confirmation among 6,873 suspected persons and relevant epidemiologic and clinical features, Saudi Arabia\u20142014 to 2019. eClinicalMedicine 41, 101191 (2021).","journal-title":"eClinicalMedicine"},{"key":"142_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2016.226","volume":"2","author":"AS Cockrell","year":"2016","unstructured":"Cockrell, A. S. et al. A mouse model for MERS coronavirus-induced acute respiratory distress syndrome. Nat. Microbiol. 2, 16226 (2016).","journal-title":"Nat. Microbiol."},{"key":"142_CR40","first-page":"E3119","volume":"114","author":"K Li","year":"2017","unstructured":"Li, K. et al. Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice. Proc. Natl. Acad. Sci. USA 114, E3119\u2013E3128 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"142_CR41","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jmb.2013.09.016","volume":"426","author":"M Fairhead","year":"2014","unstructured":"Fairhead, M., Krndija, D., Lowe, E. D. & Howarth, M. Plug-and-play pairing via defined divalent streptavidins. J. Mol. Biol. 426, 199\u2013214 (2014).","journal-title":"J. Mol. Biol."},{"key":"142_CR42","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/nprot.2008.20","volume":"3","author":"M Howarth","year":"2008","unstructured":"Howarth, M. & Ting, A. Y. Imaging proteins in live mammalian cells with biotin ligase and monovalent streptavidin. Nat. Protoc. 3, 534\u2013545 (2008).","journal-title":"Nat. Protoc."},{"key":"142_CR43","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1126\/science.1097211","volume":"305","author":"DJ Smith","year":"2004","unstructured":"Smith, D. J. et al. Mapping the antigenic and genetic evolution of influenza virus. Science 305, 371\u2013376 (2004).","journal-title":"Science"}],"container-title":["npj Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44298-025-00142-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44298-025-00142-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44298-025-00142-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T07:08:27Z","timestamp":1757315307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44298-025-00142-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["142"],"URL":"https:\/\/doi.org\/10.1038\/s44298-025-00142-9","relation":{},"ISSN":["2948-1767"],"issn-type":[{"value":"2948-1767","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,29]]},"assertion":[{"value":"18 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: Y.K. has received unrelated funding support from Daiichi Sankyo Pharmaceutical, Toyama Chemical, Tauns Laboratories, Inc., Shionogi & Co. LTD, Otsuka Pharmaceutical, KM Biologics, Kyoritsu Seiyaku, Shinya Corporation, and Fuji Rebio. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}